Calciphylaxis Market Top Key players-Amgen Inc., Smith & Nephew plc, Medtronics and 3M through 2018-2023

Market Scenario
Calciphylaxis, also known as calcific uremic arteriolopathy (CUA), is a syndrome associated with end-stage renal disease. The syndrome causes necrotic skin ulcers, which often leads to a fatal outcome. In 2008, Rogers and Coates stated that CUA is a rare but important cause of morbidity and mortality in patients with chronic kidney disease. The prevalence of CUA is increasing in patients with renal failure, and the condition is also being recognized in non-uremic patients. Calciphylaxis affects up to 4% of dialysis patients, which starts with a calcification of small peripheral vessels that quickly becomes enlarged.
The market for calciphylaxis is growing at a swift pace. Increasing prevalence of end stage renal disease has spurred the growth of the market. According to the Regents of the University of California, over 650,000 patients every year in the United States and an estimated 2 million patients worldwide are affected by end stage renal disease (ESRD). Moreover, rising number of dialysis patients has spurred the growth of this market. According to the U.S. Renal Data System Annual Data Report, more than 660,000 Americans were under treatment for end stage renal disease out of which 468,000 were dialysis patients in 2016.
View Reports Sample @ https://www.marketresearchfuture.com/sample_request/3567

However, lack of treatment availability and high cost of the existing treatment may hamper the market growth during the forecast period.
The global calciphylaxis market is expected to grow at a CAGR of 10.70% during the forecast period 2017-2023.
Intended Audience
• Pharmaceutical Companies
• Medical Devices Companies
• Research and Development (R&D) Companies
• Market Research and Consulting Service Providers
• Potential Investors
Segmentation
The global calciphylaxis market is segmented on the basis of diagnosis, treatment, and end user.
On the basis of the diagnosis, the calciphylaxis market is further segmented into deep skin biopsies, blood tests, imaging, and others. Deep skin biopsies is further segmented into shave biopsy, punch biopsy, and excisional biopsy. The blood tests is further segmented into serum parathormone levels, blood glucose levels, BUN (blood urea nitrogen), calcium levels, and others. Imaging is further segmented into magnetic resonance imaging (MRI), CT scan, ultrasound, and others.
On the basis of the applications, the market is segmented into intensive wound care, medication, therapy, clot-dissolving, and others. Intensive wound care unit is further segmented into debridement, wet dressings, and others. Medication is further segmented into cinacalcet, sodium thiosulfate, steroids, and bisphosphonates.
On the basis of end user, it is segmented into hospitals, clinics, medical research centers, academic institutes, and others.
Key Findings
• Global calciphylaxis market is expected to reach around USD 3,722.6 million by 2023
• Deep skin biopsies accounted for the largest market share in 2016 and which is projected grow at a CAGR of 10.35% during the forecast period from 2017-2023
• Americas hold the largest share of the calciphylaxis market and is expected to reach USD 1,257.0 million by 2023
• Asia Pacific is the fastest growing region across the globe and is expected to grow at a rate of CAGR 11.18% during the forecast period
Regional Analysis
The Americas dominate the global calciphylaxis market owing to the presence of strong economic condition, huge development in the healthcare domain, and focus of research institutions on updating technology for new and advanced diagnosis and treatment methods. Moreover, advanced hospitals infrastructures, and availability of skilled healthcare professional are further adding fuel to the growth of the market.
Europe holds the second position in the market on the basis of increasing emphasis on rapid diagnosis and treatment of diseases, changing lifestyle, increasing prevalence of diseases among geriatric population. Asia Pacific is the fastest growing market owing to more number of developing nations present in this region, for instance, countries like India and China. These countries are encouraging the growth of the healthcare domain. Furthermore, increasing patient population from cancer in developing countries will directly increase the demand for various diagnosis & treatment methods, which, in turn, is likely to boost the growth of the market.
The Middle East & Africa is expected to hold the least market share due to less availability of medical facilities, and less development in the healthcare domain. However, countries such as Qatar and Kuwait are focusing more on the healthcare domain and developing medical facilities, which is projected to boost the market of this region.
Request Full Report @ https://www.marketresearchfuture.com/reports/calciphylaxis-market-3567

Key Players
Some of the key players in this market are Amgen Inc., Smith & Nephew plc, Medtronics, 3M, BSN Medical, ConvaTec Inc, Sanifit, and others.

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India

This release was published on openPR.